New recommendations published
Screening and diagnoses practices vary between and within countries on how mammograms should be read and how biopsies should be performed. The evidence underpinning the recommendations published suggests very specific approaches. For example, ECIBC suggests that mammograms should be read independently by two trained readers and recommends undergoing needle core biopsy – rather fine needle aspiration cytology - for the diagnosis of a breast lesion that may represent a cancer.
For women with no symptoms and not at high risk of breast cancer, mammography screening, for example, is strongly recommended between the ages of 50 and 69. The newly published recommendations specify the optimal way of inviting women between 50 and 69 to attend their periodic screening.
Breast cancer is the most common cancer among women in the EU and data from the new European Cancer Information System (ECIS) indicate that there will be more than 400,000 new cases in 2018. Early diagnoses lead to more effective treatments and higher survival rates. These recommendations use evidence to show the advantages of population-based screening programmes, in terms of their effectiveness, coverage of the target population, and equality of access to services. Thus through ECIBC, the Commission provides concrete advice on how to plan, organise, and execute impactful screening programmes.